This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Clinical Pearls for Achieving Functional Recovery in Schizophrenia: A Patient Case Consult

Clinical Pearls for Achieving Functional Recovery in Schizophrenia: A Patient Case Consult

Format

Webcast

Time to Complete

45 minutes

Released

August 24, 2017

Expires

August 24, 2018
Add to Queue


Maximum Credits

0.75 / AMA PRA Category 1 CreditTM
0.75 / CE for Pharmacists (0.075 CEUs)

Accredited Provider


This educational initiative is provided by CME Outfitters.

Commercial Supporter

This activity is supported by an educational grant from Allergan.

Program Description

The positive symptoms of schizophrenia, such as hallucinations, delusions, and aggressive symptoms, receive the most clinical attention and are the primary targets for pharmacological treatment. Unfortunately, it is the negative and cognitive symptoms that persist longer than positive symptoms, are more difficult to treat, and contribute to chronicity and disability.1

The newer treatments that have become available are better tolerated with improved side-effect profiles and may have an important role in improving social functioning. There has been an unmet need for better tolerated antipsychotics with broad-based symptom control that improve patient functioning. Recently, FDA-approved agents that offer partial D2 receptor agonism and have other unique properties that may affect the clinical profile offer the possibility of improved symptom management and reduced adverse effects.

In this CME Outfitters patient case and expert consult Q&A session, faculty go in-depth with the case study by answering questions while offering evidence, guidelines, and quality measures to improve the long-term management of patients with schizophrenia.
____________________________________________

References
1. Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS. Update on schizophrenia and bipolar disorder: focus on cariprazine. Neuropsychiatr Dis Treat. 2016;12:1837-1842.

Intended Audience

Psychiatrists, pharmacists, and other members of the interprofessional team caring for individuals with schizophrenia

Educational Objectives

At the end of this CE activity, participants should be able to:

  • Evaluate the efficacy and safety profiles of recent FDA-approved agents to treat schizophrenia for inclusion into appropriate treatment plans
  • Incorporate into practice the latest advances in the management of schizophrenia

Conflict Of Interest Disclosure Policy

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

John M. Kane, MD
Senior Vice President for Behavioral Health Services
Northwell Health
New Hyde Park, NY
Professor and Chair, Department of Psychiatry
Hofstra Northwell School of Medicine
Hempstead, NY

Dr. Kane has disclosed that he receives grant support from Janssen Pharmaceuticals Inc. and Otsuka. He serves on the advisory board for Alkermes; Intra-Cellular Therapies, Inc.; Lundbeck; Neurocrine Biosciences Inc.; Otsuka America Pharmaceutical, Inc.; Pierre Fabre; Takeda Pharmaceuticals U.S.A., Inc.; and Teva. He serves as a consultant for Alkermes; Allergan; Eli Lilly and Company; Forum Pharmaceuticals Inc.; Genentech, Inc.; Intra-Cellular Therapies, Inc.; Janssen Pharmaceuticals, Inc.; Johnson & Johnson; Lundbeck; Neurocrine Biosciences Inc.; Otsuka America Pharmaceutical, Inc.; Pierre Fabre; Reviva Pharmaceuticals Inc.; Roche; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Teva. He is a shareholder of LB Pharmaceuticals Inc.; MedAvante Inc.; and Vanguard Research Group.

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.

Planners' and Managers' Disclosures

Kashemi D. Rorie, PhD, (planning committee) has no disclosures to report. 


Tony Graham, MD, (peer reviewer) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.

Credit

0.75

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.75

Type

CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hours (0.075 CEUs)
Universal Activity Number: 0376-0000-17-040-H01-P

Additional Credit Information

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM   through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 75% or better on the post-test. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact info@cmeoutfitters.com.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue